Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Can Low LSD Doses Address Alzheimer’s Disease?
Eleusis Is Investigating Anti-Inflammatory Properties Of Psychedelics
Dec 18 2019
•
By
Sten Stovall
Eleusis Is testing low-dose lysergic acid diethylamide for AD • Source: Shutterstock
More from Business
More from Scrip